Skip to content

Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients

Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06033807
Enrollment
31440
Registered
2023-09-13
Start date
2023-09-01
Completion date
2025-12-31
Last updated
2025-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Latent Tuberculosis Infection, Tuberculosis

Keywords

latent tuberculosis, active screening

Brief summary

The goal of this observational study is to investigate the proportion of Mycobacterium tuberculosis (MTB) infection in school contacts of active tuberculosis (ATB) patients. The main questions it aims to answer are: * the proportion of MTB infection among school contacts of ATB patients * risk factors related to tuberculosis (TB) infection * health economic evaluation of screening strategy

Interventions

DIAGNOSTIC_TESTQuantiFERON-TB Gold (QFT) test

Participants will be tested by QuantiFERON-TB Gold (QFT) test to see if they have ever infected by MTB. Those with positive results will proceed to sputum Xpert MTB/RIF, physical examination and chest CT scan, as well as sputum culture if necessary to distinguish latent TB infection (LTBI) from ATB. X-ray scan is conditional on age above 15 years with a positive QuantiFERON-TB Gold (QFT) test result.

Sponsors

Guizhou Center for Disease Control and Prevention
CollaboratorOTHER
Huashan Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
13 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 13 years old or above; * Students in junior middle school, high school and university; * Close contact of school active tuberculosis case (e.g. in the same classroom, in the same dormitory); * Himself/herself (together with his/her guardian for age under 18 years old) willing to participate in trial and sign informed consent.

Exclusion criteria

* Current clinical or sputum culture confirmed active tuberculosis * Have completed a full course of treatment for ATB or LTBI

Design outcomes

Primary

MeasureTime frameDescription
The prevalence of tuberculosis (TB) infection in school contactsbaselineThe prevalence of TB infection is defined as the number of participants with positive results in QuantiFERON-TB Gold (QFT) test in study population. Positive result in QFT test indicates higher response than the cut-off value of 0.35 IU / ml of INF-γ detected in at least one test tube (TB1 or TB2).

Secondary

MeasureTime frameDescription
AgebaselineAge as possible risk factor of tuberculosis infection
SexbaselineSex as possible risk factor of tuberculosis infection.
Vaccination history checklistbaselineBacillus Calmette-Guérin (BCG) vaccination history as possible risk factor of tuberculosis infection.
Patterns of contacting checklistbaselineDuration, size of space of exposure to active tuberculosis-infected patient; as possible risk factor of tuberculosis infection.
Co-morbidities / medical history checklistbaselineCo-morbidities / medical history \[cardiovascular disease, bronchial asthma, digestive ulcer, nephritic syndrome, glomerulonephritis, diabetes, hyperthyroidism, systemic lupus erythematosus, ankylosing spondylitis, epilepsy, schizophrenia, depression, HIV infection, glucocorticoid use, biologic agent use, immunosuppressive agent use, or other relevant co-morbidities / medical history\]; as possible risk factor of tuberculosis infection.

Countries

China

Contacts

Primary ContactQiaoling Ruan, PhD
ruan_qiao_ling@fudan.edu.cn13661856002
Backup ContactJinlan Li, MPH
740820442@qq.com13985045080

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026